SRTA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025
Revenue
72.5M
+7.6%
67.4M
+0.9%
66.8M
+35.5%
49.3M
Cost of Revenue
57.3M
+7.6%
53.3M
-3.4%
55.1M
+46.3%
37.7M
Gross Profit
15.2M
+7.8%
14.1M
+21.0%
11.7M
+0.5%
11.6M
Operating Expenses
20.6M
+20.7%
17.1M
-5.4%
18.1M
+4.9%
17.2M
R&D
0
0
+100.0%
-1354000
-398.9%
453.0K
SG&A
14.0M
-10.3%
15.6M
-7.3%
16.8M
+0.3%
16.8M
Operating Income
-5408000
-81.8%
-2974000
+53.6%
-6405000
-13.9%
-5622000
EBITDA
3.1M
+3512.8%
86.0K
+102.5%
-3397000
+13.3%
-3918000
Net Income
-10516000
-588.2%
2.2M
+124.4%
-8833000
-115.4%
57.4M
EPS (Basic)
$-0.12
-500.0%
$0.03
+130.0%
$-0.10
-114.3%
$0.70
EPS (Diluted)
$-0.12
-500.0%
$0.03
+130.0%
$-0.10
-114.3%
$0.70
Shares (Diluted)
86.2M
+1.0%
85.3M
+0.7%
84.7M
+2.8%
82.5M
Strata Critical Medical (SRTA) โ€” Financials